These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5940924)

  • 21. [Histochemical changes in the skin of patients with vitiligo during treatment with Psoralen].
    Abdullakhodzhaeva MS; Abidov MM
    Vestn Dermatol Venerol; 1968 Jan; 42(1):24-6. PubMed ID: 5741206
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complex treatment of patients with vitiligo].
    Borisenko KK
    Sov Med; 1973 Feb; 36(2):123-7. PubMed ID: 4764967
    [No Abstract]   [Full Text] [Related]  

  • 23. [Depigmenting chemical agents].
    Ortonne JP
    Ann Dermatol Venereol; 1986; 113(8):733-6. PubMed ID: 3800227
    [No Abstract]   [Full Text] [Related]  

  • 24. Mode of action of psoralens.
    el-Mofty AM
    Australas J Dermatol; 1967 Dec; 9(2):136-41. PubMed ID: 5588851
    [No Abstract]   [Full Text] [Related]  

  • 25. Discussion of a case of vitiligo.
    Lerner MR; Fitzpatrick TB; Halder RM; Hawk JL
    Photodermatol Photoimmunol Photomed; 1999 Feb; 15(1):41-4. PubMed ID: 9990671
    [No Abstract]   [Full Text] [Related]  

  • 26. Melasma.
    Scheinfeld NS
    Skinmed; 2007; 6(1):35-7. PubMed ID: 17215619
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: Effectiveness of trioxsalen therapy for vitiligo.
    Sehgal VN
    Arch Dermatol; 1974 Dec; 110(6):957-8. PubMed ID: 4441118
    [No Abstract]   [Full Text] [Related]  

  • 28. Should vitiligo be treated?
    Grimes PE; Kenney JA
    Cutis; 1983 Oct; 32(4):343-4, 346. PubMed ID: 6354615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An innoxious combination for depigmentation.
    Hongal AA; Revathi TN; Sijimol MV; Ramamurthy R
    Indian J Dermatol Venereol Leprol; 2021; 87(6):865-866. PubMed ID: 34623038
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of vitiligo with psoralens and triamcinolone by mouth.
    Farah FS; Kurban AK; Chaglassian HT
    Br J Dermatol; 1967 Feb; 79(2):89-91. PubMed ID: 6018207
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of melasma with potent topical corticosteroids.
    Kanwar AJ; Dhar S; Kaur S
    Dermatology; 1994; 188(2):170. PubMed ID: 8136550
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo.
    Sehgal VN
    Int J Dermatol; 1975 Apr; 14(3):205-8. PubMed ID: 1126780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of vitiligo with topical trimethylpsoralen and sunlight.
    Africk J; Fulton J
    Br J Dermatol; 1971 Feb; 84(2):151-6. PubMed ID: 5548464
    [No Abstract]   [Full Text] [Related]  

  • 34. Psoralene and melanogenesis in relation to vitiligo.
    Chakraborty DP; Choudhury SK; Dey RN
    Clin Chim Acta; 1976 Oct; 72(2):219-22. PubMed ID: 824075
    [No Abstract]   [Full Text] [Related]  

  • 35. [Facial melanosis (melasma)].
    Witkiewicz IM; Neering H
    Ned Tijdschr Geneeskd; 1981 Apr; 125(16):609-11. PubMed ID: 7242709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.
    Tirado-Sánchez A; Santamaría-Román A; Ponce-Olivera RM
    Int J Dermatol; 2009 Aug; 48(8):893-5. PubMed ID: 19659872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
    Adişen E; Karaca F; Oztaş M; Gürer MA
    Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
    [No Abstract]   [Full Text] [Related]  

  • 38. The Effect of Butin on the Vitiligo Mouse Model Induced by Hydroquinone.
    Huo SX; Wang Q; Liu XM; Ge CH; Gao L; Peng XM; Yan M
    Phytother Res; 2017 May; 31(5):740-746. PubMed ID: 28321929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New and experimental treatments of vitiligo and other hypomelanoses.
    Lotti T; Prignano F; Buggiani G
    Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.